Show simple item record

dc.contributor.authorGouliouris, Theodoreen
dc.contributor.authorRaven, Kathyen
dc.contributor.authorTorok, Esteeen
dc.contributor.authorPeacock, Sharonen
dc.date.accessioned2018-05-08T10:13:28Z
dc.date.available2018-05-08T10:13:28Z
dc.date.issued2018-06en
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/275605
dc.description.abstractBackground. Vancomycin-resistant enterococcal (VRE) bacteraemia has a high mortality and continues to defy control. Antibiotic risk factors for VRE bacteraemia have not been adequately defined. We aimed to determine the risk factors for VRE bacteraemia focusing on duration of antibiotic exposure. Methods. A retrospective matched nested case-control study was conducted amongst hospitalised patients at Cambridge University Hospitals NHS Foundation Trust from 1st January 2006 to 31st December 2012. Cases who developed a first episode of VRE bacteraemia were matched 1:1 to controls by length of stay, year, specialty and ward type. Independent risk factors for VRE bacteraemia were evaluated using conditional logistic regression. Results. 235 cases were compared to 220 controls. Duration of exposure to parenteral vancomycin, fluoroquinolones, and meropenem were independently associated with VRE bacteraemia. Compared to patients with no exposure to vancomycin, those who received courses of 1-3 days, 4-7 days, or greater than 7 days had a stepwise increase in risk of VRE bacteraemia (conditional odds ratio (cOR) 1.2 (95% confidence interval [CI] 0.4-3.8), 3.8 (95% CI 1.2-11.7), and 6.6 (95% CI 1.9-22.8), respectively). Other risk factors were presence of central venous catheter (cOR 8.7 [95% CI 2.6-29.5]); neutropenia (cOR 15.5 [95% CI 4.2-57.0]); hypoalbuminaemia (cOR 8.5 [95% CI 2.4-29.5]); malignancy (cOR 4.4 [95% CI 1.6-12.0]); gastrointestinal disease (cOR 12.4 [95% CI 4.2-36.8]); or hepatobiliary disease (cOR 7.9 [95% CI 2.1-29.9]). Conclusions. Longer exposure to vancomycin, fluoroquinolones, or meropenem was associated with VRE bacteraemia. Antimicrobial stewardship interventions targeting high-risk antibiotics are required to complement infection control procedures against VRE bacteraemia.
dc.description.sponsorshipT. G. is a Wellcome Trust Research Training Fellow (grant number: 103387/ Z/13/Z) and has received support from Public Health England. B. W. is an Academic Clinical Fellow supported by the National Institute for Health Research. M. E. T. is a Clinician Scientist Fellow supported by the Academy of Medical Sciences and the Health Foundation and is also supported by the National Institute for Health Research Cambridge Biomedical Research Centre. This work was also supported by the Health Innovation Challenge Fund (WT098600, HICF-T5–342), a parallel funding partnership between the Department of Health and Wellcome Trust
dc.publisherOUP
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleDuration of exposure to multiple antibiotics is associated with increased risk of vancomycin-resistant enterococcal bacteraemia: a nested case-control studyen
dc.typeArticle
prism.endingPage1699
prism.issueIdentifier6en
prism.publicationDate2018en
prism.publicationNameJournal of Antimicrobial Chemotherapyen
prism.startingPage1692
prism.volume73en
dc.identifier.doi10.17863/CAM.22856
dcterms.dateAccepted2018-02-19en
rioxxterms.versionofrecord10.1093/jac/dky075en
rioxxterms.versionVoR*
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/en
rioxxterms.licenseref.startdate2018-06en
dc.contributor.orcidTorok, Estee [0000-0001-9098-8590]
dc.contributor.orcidPeacock, Sharon [0000-0002-1718-2782]
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idWellcome Trust (103387/Z/13/Z)
pubs.funder-project-idWellcome Trust (098600/Z/12/Z)
pubs.funder-project-idAcademy of Medical Sciences (unknown)
pubs.funder-project-idWellcome Trust (094882/Z/10/Z)
cam.issuedOnline2018-03-13en
cam.orpheus.counter1*


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International